105 related articles for article (PubMed ID: 16352787)
1. Routine vs selective invasive strategies in acute coronary syndromes.
Bavry AA; Kumbhani DJ
JAMA; 2005 Dec; 294(22):2844-5; author reply 2845-6. PubMed ID: 16352787
[No Abstract] [Full Text] [Related]
2. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes.
Campbell P
N Engl J Med; 2001 Nov; 345(21):1573-4; author reply 1574-5. PubMed ID: 11794228
[No Abstract] [Full Text] [Related]
3. Fast, aggressive treatment for myocardial infarction urged.
Mitka M
JAMA; 2000 Dec; 284(23):2985-6. PubMed ID: 11122567
[No Abstract] [Full Text] [Related]
4. Timing of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Naina HV; Harris S; Singla A
JAMA; 2007 Jul; 298(1):37; author reply 37-8. PubMed ID: 17609485
[No Abstract] [Full Text] [Related]
5. Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.
Stone GW; Bertrand ME; Moses JW; Ohman EM; Lincoff AM; Ware JH; Pocock SJ; McLaurin BT; Cox DA; Jafar MZ; Chandna H; Hartmann F; Leisch F; Strasser RH; Desaga M; Stuckey TD; Zelman RB; Lieber IH; Cohen DJ; Mehran R; White HD;
JAMA; 2007 Feb; 297(6):591-602. PubMed ID: 17299194
[TBL] [Abstract][Full Text] [Related]
6. Acute coronary syndrome: new advances and nursing strategies.
Palatnik AM
Dimens Crit Care Nurs; 2000; 19(5):22-6. PubMed ID: 11998062
[TBL] [Abstract][Full Text] [Related]
7. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E;
N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424
[TBL] [Abstract][Full Text] [Related]
8. Managing unstable angina in high-risk patients.
Chew DP; Moliterno DJ
J Invasive Cardiol; 2002 Feb; 14 Suppl A():31A-48A. PubMed ID: 11847404
[No Abstract] [Full Text] [Related]
9. Introduction to "Optimizing management of non-ST-segment elevation acute coronary syndromes". Harmonizing advances in mechanical and pharmacologic intervention.
Boden WE; Pepine CJ
J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):1S-6S. PubMed ID: 12644334
[No Abstract] [Full Text] [Related]
10. Drawbacks of nonrandomized trials in acute coronary syndromes.
Biondi-Zoccai GG; Abbate A; Agostoni P; Valgimigli M; Sangiorgi GM
Am J Cardiol; 2006 Jan; 97(1):151. PubMed ID: 16377303
[No Abstract] [Full Text] [Related]
11. Using eptifibatide in patients undergoing coronary angioplasty with acute myocardial infarction.
Wong CB
Catheter Cardiovasc Interv; 2003 Nov; 60(3):423-4; author reply 424. PubMed ID: 14571498
[No Abstract] [Full Text] [Related]
12. GUSTO IV: expanding therapeutic options in acute coronary syndromes.
Lincoff AM
Am Heart J; 2000 Dec; 140(6 Suppl):S103-14. PubMed ID: 11100004
[No Abstract] [Full Text] [Related]
13. Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature.
Bavry AA; Kumbhani DJ; Quiroz R; Ramchandani SR; Kenchaiah S; Antman EM
Am J Cardiol; 2004 Apr; 93(7):830-5. PubMed ID: 15050484
[TBL] [Abstract][Full Text] [Related]
14. [Acute coronary ischemic syndrome without ST elevation. Role of glycoprotein IIB/IIIA inhibitors and percutaneous coronary interventions].
Peña Duque MA
Arch Cardiol Mex; 2006; 76 Suppl 2():S249-51. PubMed ID: 17017111
[TBL] [Abstract][Full Text] [Related]
15. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
[TBL] [Abstract][Full Text] [Related]
16. ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations.
American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)
Catheter Cardiovasc Interv; 2000 Dec; 51(4):505-21. PubMed ID: 11108692
[No Abstract] [Full Text] [Related]
17. Glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST segment elevation myocardial infarction.
Cannon CP
Coron Artery Dis; 1999 Dec; 10(8):561-6. PubMed ID: 10599534
[No Abstract] [Full Text] [Related]
18. [Glycoprotein IIb/IIIa antagonists].
Hennemann A
Med Monatsschr Pharm; 2000 Dec; 23(12):385-90. PubMed ID: 11147193
[No Abstract] [Full Text] [Related]
19. Use of glycoprotein IIb/IIIa inhibitors in invasively-treated patients with non-ST elevation acute coronary syndrome.
De Servi S; Mariani M; Vandoni P; Dellavalle A; Politi A; Poletti F; Bonizzoni E; Leoncinie M;
J Cardiovasc Med (Hagerstown); 2006 Mar; 7(3):159-65. PubMed ID: 16645379
[TBL] [Abstract][Full Text] [Related]
20. Acute coronary syndromes and diabetes mellitus.
Trichon BH; Roe MT
Diab Vasc Dis Res; 2004 May; 1(1):23-32. PubMed ID: 16305052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
